2014/2562(DEA)
Situations in which post-authorisation efficacy studies may be required
Basic information
2014/2562(DEA)
DEA - Delegated acts procedure
Supplementing 2001/0252(COD)
Subject
4.20.04 Pharmaceutical products and industry
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed ENVIEnvironment, Public Health and Food Safety
Key events
Date | Event | Reference | Summary |
---|---|---|---|
03/02/2014 | Non-legislative basic document published | C(2014)00432 | |
03/02/2014 | Initial period for examining delegated act 2.0 month(s) | ||
05/02/2014 | Committee referral announced in Parliament | ||
15/04/2014 | Delegated act not objected by Parliament |
Technical information
Procedure | Information |
---|---|
Procedure reference | 2014/2562(DEA) |
Procedure type | DEA - Delegated acts procedure |
Nature of procedure | Examination of delegated act |
Supplementing 2001/0252(COD) | |
Stage reached in procedure | Procedure completed - delegated act enters into force |
Committee dossier |
ENVI/7/15178
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2014)00432 03/02/2014